Literature DB >> 20214584

Inorganic engineered nanoparticles and their impact on the immune response.

Ralph A Sperling1, Eudald Casals, Joan Comenge, Neus G Bastús, Victor F Puntes.   

Abstract

The immune system is the responsible for body integrity and the prevention of external invasion. In principle, the immune system has not been evolutionarily trained to respond against inorganic engineered nanoparticles (NPs). However, how it will react against them will determine developments on the use of NPs as medical devices and their toxicological impact on human and environmental health. Initial observations show a broad range of results as a function of size, shape, concentration and surface state of NPs, and a variety of immune responses from absent to acute inflammation. In particular for the case of NP, the composition of the material, which strongly influences its physical properties, appears not to be the main determining factor for their behavior in biological environments as compared to surface state or size.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20214584     DOI: 10.2174/138920009790274577

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  7 in total

1.  Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.

Authors:  Krishnan V Chakravarthy; Adela C Bonoiu; William G Davis; Priya Ranjan; Hong Ding; Rui Hu; J Bradford Bowzard; Earl J Bergey; Jacqueline M Katz; Paul R Knight; Suryaprakash Sambhara; Paras N Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

Review 2.  Toxicity of engineered nanomaterials: a physicochemical perspective.

Authors:  Ramakrishna Podila; Jared M Brown
Journal:  J Biochem Mol Toxicol       Date:  2012-11-05       Impact factor: 3.642

3.  Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects.

Authors:  Gertie J Oostingh; Eudald Casals; Paola Italiani; Renato Colognato; René Stritzinger; Jessica Ponti; Tobias Pfaller; Yvonne Kohl; Daniëlla Ooms; Flavia Favilli; Hilde Leppens; Davide Lucchesi; François Rossi; Inge Nelissen; Hagen Thielecke; Victor F Puntes; Albert Duschl; Diana Boraschi
Journal:  Part Fibre Toxicol       Date:  2011-02-09       Impact factor: 9.400

4.  Contribution of engineered nanomaterials physicochemical properties to mast cell degranulation.

Authors:  Monica M Johnson; Ryan Mendoza; Achyut J Raghavendra; Ramakrishna Podila; Jared M Brown
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

5.  Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin.

Authors:  Joan Comenge; Carmen Sotelo; Francisco Romero; Oscar Gallego; Agustí Barnadas; Tomás García-Caballero Parada; Fernando Domínguez; Víctor F Puntes
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

6.  Detection of quadruplex DNA by gold nanoparticles.

Authors:  Heather F Crouse; Alex Doudt; Cassie Zerbe; Swarna Basu
Journal:  J Anal Methods Chem       Date:  2012-03-27       Impact factor: 2.193

Review 7.  Drug Delivery Strategies for Enhancing the Therapeutic Efficacy of Toxin-Derived Anti-Diabetic Peptides.

Authors:  Reeju Amatya; Taehoon Park; Seungmi Hwang; JaeWook Yang; Yoonjin Lee; Heesun Cheong; Cheol Moon; Hyun Duck Kwak; Kyoung Ah Min; Meong Cheol Shin
Journal:  Toxins (Basel)       Date:  2020-05-10       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.